Töteberg-Harms M, Wachtl J, Schweier C, Funk J, Kniestedt C
UniversityHospital Zurich, Department of Ophthalmology, Zurich, Switzerland.
Augenklinik, Klinikum Chemnitz.
Klin Monbl Augenheilkd. 2017 Apr;234(4):457-463. doi: 10.1055/s-0043-100291. Epub 2017 Mar 6.
Combined cataract and glaucoma procedures, and minimally-invasive glaucoma surgery in particular, have gained increasing interest over the past few years. The aim of this study was to compare the long-term efficacy of combined phaco-trabeculectomy (Phaco-Trab) and combined phacoemulsification plus excimer laser trabeculotomy (Phaco-ELT). Retrospective, non-randomised, comparative, interventional case series of consecutive patients after Phaco-Trab and Phaco-ELT at the University Hospital of Zurich and the Talacker Eye Center Zurich in Switzerland. Inclusion criteria were diagnosis of glaucoma plus vision-impairing coexisting cataract. Primary outcome measures were change in intraocular pressure (IOP), number of anti-glaucoma drugs (AGDs), and best-corrected visual acuity (BCVA) 1 year and 4 years after the procedure. Secondary outcome measures were surgical complications and requirement of postoperative interventions. Success was defined based on the criteria of the Tube-versus-Trabeculectomy study. Mean age was 76.1 ± 8.6 years (29.2 % males; 47.8 % right eyes). Phaco-Trab (n = 62) decreased median IOP from 22.8 to 13.0 at 1 year and to 14.0 mmHg at 4 years. AGDs were reduced from 2 drugs to 0 AGDs at 1 year and 4 years. Median BCVA improved from 0.2 logMAR to 0.0 logMAR at 1 year and 4 years. Phaco-ELT (n = 51) lowered median IOP from 19.0 to 15.0 at 1 year and to 14.0 mmHg (p = 0.002) at 4 years. AGDs were reduced from 2 drugs to 1 AGD at 1 year and 4 years (p = 0.002). BCVA improved from 0.4 logMAR to 0.1 logMAR after 1 year and 4 years. If not stated otherwise, all changes compared to baseline were highly significant (p < 0.001). No perioperative complications occurred; postoperative interventions were performed in 74 % of Phaco-Trab patients. Both surgical procedures reduced IOP and AGDs and improved BCVA significantly and persistently during the entire follow-up period of 4 years with a good safety profile. This study validates Phaco-ELT as an option when post-operative target pressure in the mid-teens would be adequate, whereas Phaco-Trab would be the treatment of choice when IOP in the low teens is desired.
在过去几年中,白内障与青光眼联合手术,尤其是微创青光眼手术,已引起越来越多的关注。本研究的目的是比较白内障超声乳化小梁切除术(Phaco-Trab)与白内障超声乳化联合准分子激光小梁切开术(Phaco-ELT)的长期疗效。这是一项回顾性、非随机、对比性、介入性病例系列研究,研究对象为瑞士苏黎世大学医院和苏黎世塔拉克眼科中心接受Phaco-Trab和Phaco-ELT手术的连续患者。纳入标准为青光眼诊断且伴有影响视力的并存白内障。主要观察指标为术后1年和4年时眼压(IOP)的变化、抗青光眼药物(AGD)的数量以及最佳矫正视力(BCVA)。次要观察指标为手术并发症和术后干预需求。成功的定义基于“引流管与小梁切除术”研究的标准。平均年龄为76.1±8.6岁(男性占29.2%;右眼占47.8%)。Phaco-Trab组(n = 62)在术后1年时眼压中位数从22.8降至13.0,4年时降至14.0 mmHg。AGD数量在1年和4年时从2种减少至0种。BCVA中位数在1年和4年时从0.2 logMAR提高至0.0 logMAR。Phaco-ELT组(n = 51)在术后1年时眼压中位数从19.0降至15.0,4年时降至14.0 mmHg(p = 0.002)。AGD数量在1年和4年时从2种减少至1种(p = 0.002)。BCVA在1年和4年后从0.4 logMAR提高至0.1 logMAR。除非另有说明,与基线相比的所有变化均具有高度显著性(p < 0.001)。未发生围手术期并发症;74%的Phaco-Trab患者进行了术后干预。在整个4年的随访期内,两种手术均显著且持续地降低了眼压和AGD数量,并改善了BCVA,安全性良好。本研究证实,当术后目标眼压在十几mmHg中期足够时,Phaco-ELT是一种选择,而当期望眼压在十几mmHg低水平时,Phaco-Trab将是首选治疗方法。